سعر ستربتولاز 1.5مليون وحدة دولية فيال وريد 1,500,000 وحدة دولية per vial 2022

Streptolase: streptokinase 1,500,000 IU powder in a vial for intravenous infusion; a fibrinolytic enzyme used for thrombolysis (e.g. acute myocardial infarction, thromboembolism) in hospital.

• Treatment of acute myocardial infarction within 24 hours of symptom onset.Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland
• Dissolution of thrombi and emboli in extensive deep vein thrombosis, pulmonary embolism, acute or subacute peripheral arterial occlusion and central retinal venous or arterial thrombosis.Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland

• Conditions with existing or very recent haemorrhage: active internal bleeding, recent cerebrovascular accident, intracranial or intraspinal surgery, known intracranial neoplasm, severe uncontrolled hypertension, uncontrolled clotting disorders.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
• Previous severe allergic reaction to streptokinase; streptokinase therapy more than 5 days and less than 12 months previously, or recent streptococcal infection with high antistreptokinase titres.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
• Pregnancy, recent surgery, delivery or abortion, severe liver or kidney damage, acute pancreatitis, subacute bacterial endocarditis, severe hypertension (>200/100 mmHg).International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland

• Antistreptokinase titre rises 7-10 days after treatment and stays raised for about 12 months; repeat therapy only with great caution.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
• Avoid intramuscular injections during therapy; caution in mitral valve disease or atrial fibrillation (risk of cerebral embolism).International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland

• Anticoagulants and drugs affecting platelets (e.g. acetylsalicylic acid, heparin, coumarins, NSAIDs, dipyridamole)Increased risk of haemorrhage.Health Products Regulatory Authority (HPRA), Ireland

• Contraindicated in pregnancy.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland

• Streptokinase: Forms a complex with plasminogen that converts plasminogen to plasmin, leading to fibrin clot lysis.